Hepatitis B continues to affect a significant portion of Uganda's population, with 4.1% of adults living with the virus, according to Uganda Population-based HIV impact assessment survey 2016.

Menzies School of Health Research has led the largest-ever study of people living with a unique strain of chronic hepatitis B ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organisation (WHO) has for the first time recommended the use of injectable lenacapavir (LEN) as a ...

The World Health Organization said infections more than doubled in Europe and Central Asia between 2023 and 2024 ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Thousands of employees across US federal health agencies received an email Monday afternoon telling them they were out of a job as of the close of business.

IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. Four ...

This landmark policy action aims to reshape the global HIV response by providing a highly effective, long-acting alternative ...